-
Galloway accuser could not foresee publishing-sector fallout, lawyer argues
-
No. 22 UCLA defeats No. 5 Arizona 84-75 despite Kharchenkov's 38 points
-
New York City Center revives In the Heights as a timely community story
-
Vessel operator seeks witnesses after Vancouver grounding
-
Godzilla Minus Zero shifts focus toward postwar human drama
-
US Air Force deploys F-16 fighters to remote Aleutian base for readiness drill
-
Mehbooba Mufti urges dialogue and renewed Central Asia links for Kashmir
-
Bezos grant helps Seattle nonprofit move thousands of families toward housing
-
Seacliff Healthcare Seeks Specialist GP in Thirroul
-
Shrini Srivastava joins crew of Varanasi-Delhi Vande Bharat Sleeper service
-
US stocks fall before midterm Election Day as technology shares weaken
-
Nearly Half of Australian Workers Overqualified, Survey Finds
-
BLS Polymers makes strong market debut at ₹248 per share
-
RBI eases export-declaration compliance for individual service exporters
-
Petrol and diesel prices remain broadly steady across major Indian cities
-
India proposes more import entry points for drugs and medical devices
-
Reliance shares remain in focus after near-12% surge
-
Derek Tierney Outlines Ten-Year Strategy for National Digital Health System
-
2026 Arizona Midterms: Key Races, Ballot Measures, and Voter Deadlines
-
NBC’s Steve Kornacki Reveals Tech Habits Ahead of Midterm Elections
-
Coal India prepares possible $1 billion Mahanadi Coalfields listing
-
India and Israel oppose UN draft on regional conventional arms control
-
Julia Stiles and Ezra Sosa Share Emotional Farewell After 'DWTS' Elimination
-
BLS Polymers shares open 65.3% above IPO price
-
US Buildings Threatened by Wildfires Could Triple by 2060
-
Capital-markets shares rally as Motilal Oswal and Angel One lead gains
-
Why Pregnancy Cost Estimates Fail: A Family’s $9,000 Surprise
-
Latino Voters Defy ICE Fears, Turn Out in Record Numbers for Midterms
-
US Strikes Iranian Targets in Strait of Hormuz Ahead of Midterms
-
ITC shares rise as analysts anticipate gradual cigarette-business recovery
-
Brodeur’s Overtime Goal Secures Bethlehem’s Second Consecutive Sectional Title
-
Reliance rally puts historical one-year return pattern in focus
-
Rare 1970 Plymouth ‘Cuda 426 Hemi Listed for $400,000
-
Kuwait edges Oman 1-0 in veterans Gulf Cup in Doha
-
The Digital Burden: Why Instant Messaging Feels Like a Full-Time Job
-
Saudi Aramco quarterly profit climbs 34.6% amid elevated oil prices
-
Alberta Tabled Controversial Riding Boundary Maps Amid Gerrymandering Accusations
-
Washington reports movement in Iran negotiations aimed at preventing escalation
-
Hong Kong court set to sentence activist Joshua Wong in security case
-
Korea’s Labor Share of GDP Hits Record Low Amid Semiconductor Boom
-
Australia raises benchmark rate to highest level in 18 years
-
littlefish and Halo Dot Partner to Replace Payment Terminals with SoftPOS
-
'The Remarried Empress' Cast Discusses Bringing Fantasy Royal Drama to Life
-
Kuwait inspectors destroy 115 kilograms of unverified meat in Farwaniya
-
Asian stocks retreat as AI worries outweigh steep oil-price drop
-
Egypt Accelerates Construction of 341km Sinai Railway Linking Arish and Taba
-
Hamad International Airport stages emergency drills during WATAN 2026
-
John Schneider Admits Owes Millions in 'Dukes of Hazzard' Divorce Battle
-
Global failure to punish attacks leaves journalists at continuing risk
-
Philippine Authorities Report Progress in Thomas Markle Sr. Child Pornography Probe
Dogs die as South Africa snake antivenom shortage bites
Zarza, a much-loved Staffordshire terrier, ended up at a South African animal hospital with a bite from a Mozambique spitting cobra on her snout.
The snake's powerful venom can stop the breathing muscles from working, but normally the bites are treatable with an antidote.
The problem, say South African veterinarians, is that they currently have virtually no vials of the antiserum left.
"We've been out of antivenom for quite some months now," said Dean de Kock, a vet at the Valley Farm Animal Hospital in Pretoria, where Zarza was treated but eventually died.
Vets and snake experts say the shortage started getting serious towards the end of last year -- though the authorities are denying there is a problem.
"Snakebite antivenom is available in the country," the National Health Laboratory Service (NHLS), a government body in charge of antidote production, told AFP.
Experts in the field disagree.
- A 'countrywide shortage' -
In April, a group of snakebite treatment specialists pleaded with the health minister over what they described as "a major health risk".
While the supply problems may be easing in some quarters, vets say they are still struggling.
Hospitals treating humans get priority when any new doses come available, said Johan Marais, a herpetologist -- specialist in reptiles and amphibians -- who heads the African Snakebite Institute.
"At the moment, if you're a veterinarian, you cannot get antivenom," said Marais, 65.
Speaking from his headquarters in Pretoria, he casually handled a black mamba during his conversation with AFP.
He said he receives up to a dozen calls a day from desperate animal doctors and dog owners looking for antidotes.
"If your dog gets a serious snakebite today, there's a likelihood it's going to die," Marais said.
Alan Kloeck, of the South African Veterinary Association, confirmed Marais's remarks, describing a "countrywide shortage" with vets unable to get their hands on the antiserum they needed.
- Horse blood, spitting cobras -
South Africa is home to about 160 species of snakes, many of them poisonous.
South African Vaccine Producers -- a NHLS subsidiary and the only antivenom maker in the country -- produces two antidotes.
One can treat bites from 10 snakes including the cape cobra, the puff adder and the green mamba, while another is for relatively rare boomslang bites.
Making the antiserums is a laborious process, said Mike Perry of African Reptiles and Venom, a venom-extraction firm in Centurion, outside Johannesburg, that houses around 900 snakes in small glass cages.
He said his team forces the hissing reptiles to spit out their poison by forcing them to bite a glass jar.
Small quantities of the toxins are then injected into horses, which over time develop immunity.
Their plasma is then harvested and processed to make the serum.
But that process requires constant refrigeration, and the production backlog has been blamed in large part on South Africa's energy crisis, which has caused repeated power blackouts.
In April, NHLS said it required "a consistent and dependable power supply" to produce antivenom.
The continuous switchover to generators during outages interrupted production and affected stockpiles, it said, forcing it to invest in backup power systems and renewable energy.
- 'Last vial' -
Last week, NHLS said it had increased manufacturing in recent months.
Since January, it said, it had delivered antivenom to more than 230 institutions, including hospitals and veterinary clinics, fulfilling all orders apart from "a small backlog" affecting a provincial depot.
But de Kock, whose veterinary practice is in a different province, has not received any shipments since December. For a while, they were using expired doses from other hospitals, but these too have dried up.
"We have used the last vial on Sunday evening," he said last week.
Over the past three months, the hospital treated 25 dogs for snakebites.
Of the 16 who could get expired antivenom, only one did not survive, while six of the nine who could not get doses died.
Zarza was among them, dying in May after a two-day struggle on a ventilator.
"It's tough," said de Kock, 53. "You're doing everything you can but the vital thing that you actually need is the antivenom, and you don't have that".
His hope was that the austral winter months, when snakes are less active, would bring some relief.
O.Krause--BTB